Page 379 - PROGRAMME2018

Wednesday, 4 July 2018
08:30 - 09:45 Company Symposium Abbott Products Operations
“Dydrogesterone: Shining New Light on Life”
Chairmen: Herman Tournaye Georg Griesinger
08:30 - 08:40 08:40 - 09:00 09:00 - 09:20 09:20 - 09:40 09:40 - 09:45 09:45
12:00 - 13:15
Opening
H. Tournaye
Do Progestogens Fit in the ESHRE Guidelines for Treatment of Recurrent Miscarriage
Prof. Carp
Luteal Support in ART: Could Dydrogesterone Become the New Gold Standard?
Prof. Blockeel
Immunomodulation in Early Pregnancy
Prof. Arck
Ending
G. Griesinger
Close
Company Symposium Japan A-PART & Vitrolife
“How time-lapse technology can improve clinical outcome in natural and mild stimulation cycles”
Chairmen: Dr Hiroaki Yoshida (president of Japan A-PART, Sendai ART Clinic, Japan Dr Markus Montag, ilabcomm, Germany
• Introduction to A-PART and IVF market in Japan Dr Hiroaki Yoshida (Sendai ART Clinic, Japan)
• The role of time-lapse technology in mild/low stimulation program Dr Keiichi Kato (Kato Ladies Clinic, Japan)
• The development and application of algorithms specific to mild/low stimulation Dr Markus Montag (ilabcomm, Germany)
• The big picture: how traditional grading, PGS and time-lapse complement each other Dr Cristina Hickman (British Fertility Society & Imperial College London, UK)
FINAL PROGRAMME I BARCELONA, SPAIN – 1 TO 4 JULY 2018
379
COMPANY SYMPOSIA